Focus: NFANT Labs is a pre-revenue biotechnology company focused on developing a neonatal intensive care unit (NICU) feeding device to address prematurity-related complications. The company operates at an early stage with minimal disclosed operational scale.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About NFANT Labs
AI assessmentNot HiringNo open roles listed right now. Follow NFANT Labs to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
nfant
PrematurityClinical Trials (1)
NCT04256889Use Of Nfant(R) Technology Feeding System For Infants Less Than 30 Weeks GA
N/AHelp build intelligence for NFANT Labs
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.